Baker Bros. Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-75,357
| Closed | -$2.52M | – | 124 |
|
|
2016
Q4 | $2.52M | Hold |
75,357
| – | – | 0.02% | 85 |
|
|
2016
Q3 | $2.01M | Hold |
75,357
| – | – | 0.02% | 96 |
|
|
2016
Q2 | $1.66M | Hold |
75,357
| – | – | 0.02% | 105 |
|
|
2016
Q1 | $2.21M | Hold |
75,357
| – | – | 0.02% | 98 |
|
|
2015
Q4 | $2.49M | Hold |
75,357
| – | – | 0.02% | 101 |
|
|
2015
Q3 | $2.72M | Hold |
75,357
| – | – | 0.03% | 94 |
|
|
2015
Q2 | $3.39M | Hold |
75,357
| – | – | 0.03% | 88 |
|
|
2015
Q1 | $2.31M | Hold |
75,357
| – | – | 0.02% | 100 |
|
|
2014
Q4 | $3.83M | Hold |
75,357
| – | – | 0.04% | 80 |
|
|
2014
Q3 | $2.98M | Hold |
75,357
| – | – | 0.04% | 78 |
|
|
2014
Q2 | $3.25M | Sell |
75,357
-5,600
| -7% | -$241K | 0.04% | 81 |
|
|
2014
Q1 | $3.24M | Sell |
80,957
-28,140
| -26% | -$1.13M | 0.04% | 83 |
|
|
2013
Q4 | $2.98M | Sell |
109,097
-15,903
| -13% | -$434K | 0.04% | 73 |
|
|
2013
Q3 | $2.87M | Hold |
125,000
| – | – | 0.04% | 69 |
|
|
2013
Q2 | $2.21M | Buy |
+125,000
| New | +$2.21M | 0.04% | 61 |
|